Ligand to Participate in September Investor Conferences

manilatimes.net · 2026-08-26

JUPITER, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced its senior management team will participate in the following upcoming investor conferences:

TickrTrends take: Ligand Pharmaceuticals' participation in September investor conferences provides an opportunity for management to address investor concerns and discuss the company's pipeline and financial prospects directly with the market. Given TickrTrends' current assessment that LGND is overvalued, investors attending these conferences may scrutinize management's guidance on revenue growth, margin expansion, and return on capital to determine whether the current valuation is justified. For valuation-focused readers, these conferences represent a key moment to evaluate whether management commentary supports the stock's recent pricing or suggests further compression may be warranted.

Read the full story at manilatimes.net →